Bicocca Open Archive

Logo unimib boa
ALBERTI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.570
AS - Asia 19.504
EU - Europa 12.380
SA - Sud America 2.113
Continente sconosciuto - Info sul continente non disponibili 1.922
AF - Africa 371
OC - Oceania 66
Totale 65.926
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.987
VN - Vietnam 6.093
SG - Singapore 5.488
IT - Italia 3.959
CN - Cina 3.214
HK - Hong Kong 1.998
RU - Federazione Russa 1.640
DE - Germania 1.584
BR - Brasile 1.559
CA - Canada 1.272
SE - Svezia 1.134
IE - Irlanda 894
GB - Regno Unito 727
IN - India 531
FR - Francia 490
KR - Corea 402
UA - Ucraina 399
BD - Bangladesh 383
FI - Finlandia 314
TR - Turchia 228
AR - Argentina 203
JP - Giappone 196
ID - Indonesia 190
ES - Italia 168
NL - Olanda 166
AT - Austria 161
IQ - Iraq 141
LT - Lituania 136
DK - Danimarca 132
MX - Messico 127
ZA - Sudafrica 114
PK - Pakistan 107
CH - Svizzera 98
PL - Polonia 91
EC - Ecuador 87
SA - Arabia Saudita 86
CO - Colombia 79
PH - Filippine 70
BE - Belgio 68
VE - Venezuela 67
AU - Australia 61
MA - Marocco 49
UZ - Uzbekistan 44
JM - Giamaica 41
MY - Malesia 39
EG - Egitto 38
TW - Taiwan 36
PY - Paraguay 33
CR - Costa Rica 32
CL - Cile 31
ET - Etiopia 31
GR - Grecia 31
TN - Tunisia 28
IL - Israele 26
AE - Emirati Arabi Uniti 25
RO - Romania 25
TH - Thailandia 25
JO - Giordania 24
PE - Perù 23
KE - Kenya 22
KZ - Kazakistan 22
PT - Portogallo 22
DZ - Algeria 21
GT - Guatemala 21
CZ - Repubblica Ceca 19
HN - Honduras 19
IR - Iran 19
AZ - Azerbaigian 18
AL - Albania 16
NP - Nepal 16
BG - Bulgaria 15
BO - Bolivia 15
NI - Nicaragua 15
UY - Uruguay 15
OM - Oman 14
EU - Europa 13
HR - Croazia 13
HU - Ungheria 13
TT - Trinidad e Tobago 13
AO - Angola 11
BH - Bahrain 11
LY - Libia 11
PA - Panama 11
LV - Lettonia 10
NG - Nigeria 10
PS - Palestinian Territory 10
LB - Libano 9
NO - Norvegia 8
SC - Seychelles 8
SI - Slovenia 8
EE - Estonia 7
KG - Kirghizistan 7
MD - Moldavia 7
SV - El Salvador 7
DO - Repubblica Dominicana 6
BB - Barbados 5
BN - Brunei Darussalam 5
CI - Costa d'Avorio 5
PR - Porto Rico 5
RS - Serbia 5
Totale 63.932
Salva come PNG Salva come JPEG
Città #
Singapore 3.184
Ann Arbor 3.162
Dallas 2.785
Ashburn 2.483
San Jose 2.239
Hong Kong 1.940
Ho Chi Minh City 1.837
Hanoi 1.531
Milan 1.429
Toronto 906
Dublin 865
Fairfield 861
Woodbridge 833
Wilmington 798
Frankfurt am Main 777
Chandler 719
New York 636
Houston 601
Santa Clara 599
Los Angeles 591
Council Bluffs 569
Dearborn 505
Chicago 437
Seattle 405
Beijing 400
Hefei 393
Jacksonville 391
Princeton 337
Seoul 332
The Dalles 299
Cambridge 293
Rome 292
Boardman 266
Nanjing 214
Lauterbourg 209
Da Nang 202
Columbus 198
Buffalo 197
Haiphong 196
Munich 193
Helsinki 171
Shanghai 166
São Paulo 164
Moscow 151
Guangzhou 150
Ha Long 136
Phoenix 128
Orem 123
Vienna 123
Jakarta 119
Vilnius 115
Hải Dương 112
Biên Hòa 108
Quận Bình Thạnh 108
Tokyo 104
Lawrence 99
London 98
Montreal 97
Atlanta 95
Turin 95
Chennai 88
Denver 85
Ninh Bình 85
Can Tho 83
Thái Nguyên 81
Brooklyn 79
Altamura 77
Vũng Tàu 76
Bắc Ninh 74
Dong Ket 69
San Diego 68
Warsaw 66
Zurich 65
Baghdad 63
Basingstoke 63
Nuremberg 61
Quận Một 60
Stockholm 60
Manchester 58
Rio de Janeiro 58
Shenyang 58
Amsterdam 56
Nanchang 56
Boston 55
Lachine 55
Andover 53
Poplar 53
Changsha 52
Bắc Giang 51
Figino 51
Hangzhou 51
Tianjin 51
Washington 51
San Francisco 50
Florence 48
Kent 46
Naples 46
Carate Brianza 45
Pune 45
Brussels 44
Totale 40.002
Salva come PNG Salva come JPEG
Nome #
Oxaliplatin-induced Alteration of Sodium-Calcium Exchanger as a Pivotal Element Leading to Peripheral Neurotoxicity and Necroptosis 828
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 803
High-Resolution MRI for Peripheral Nervous System Imaging: Volumetric Rendering in Rodent Models 653
SODIUM-CALCIUM EXCHANGER PIVOTAL ROLE IN OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY, AXONAL DAMAGE AND NECROPTOSIS 652
Sodium-Calcium Exchanger 2 Role In An In Vitro Oxaliplatin-Induced Peripheral Neurotoxicity Model 644
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 601
Translational Approach to Oxaliplatin Induced Peripheral Neurotoxicity - Neurophysiology: the Link between Bed and Bench "side" 558
In vitro neurotoxicity testing: lessons from chemotherapy-induced peripheral neurotoxicity 538
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 532
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients 520
A PILOT STUDY ON HEALTH-ECONOMICS BURDEN DUE TO CHEMOTHERAPY-INDUCED NEUROTOXICITY 518
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 493
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 485
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 475
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 471
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 462
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 451
Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review 445
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 444
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 443
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 438
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 424
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 422
Neuropatie periferiche da chemioterapia 417
Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity 416
Guillain-Barré syndrome related to COVID-19 infection 411
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 406
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 401
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 401
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 394
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 394
3D Digital tools in human anatomy teaching from peer-to-peer tutoring to clinically oriented approaches: a single center experience. 389
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 377
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 369
Oxaliplatin-induced Peripheral Neurotoxicity: role of ion channels/transporters in axonal damage. 366
3D Digital tools in neuro-anatomy teaching: from peer-to-peer tutoring to clinically oriented approaches 363
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 362
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 350
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 346
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 346
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 345
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 344
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 343
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 341
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 340
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 338
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 338
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)—a white paper 337
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 330
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 330
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin 327
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 325
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 324
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 320
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 320
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 319
In vivo study of Carfilzomib-Induced Neuropathy 319
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 318
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 318
Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care—an international Delphi study 317
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 316
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: A genome-wide study replication and meta-analysis 313
Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue 309
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 308
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer 306
Severe, reversible nelarabine-induced neuropathy and myelopathy 305
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 305
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 304
A Longitudinal Study on Oxaliplatin Induced Peripheral Neuropathy – Incidence and Facts About the “Real Life” Population And Actual Dose 303
Guillain–Barré Syndrome Associated with COVID-19 303
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNoms study 302
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 299
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 299
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 299
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 297
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 295
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 291
SODIUM-CALCIUM EXCHANGER PIVOTAL ROLE IN OXALIPLATIN-INDUCED ALTERATIONS LEADING TO PERIPHERAL NEUROTOXICITY, AXONAL DAMAGE AND NECROPTOSIS 290
Histone deacetylases inhibitors: a new frontier for neuroprotection? 290
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools 288
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients 287
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 285
Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: pilot and feasibility study. 282
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin 281
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 280
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 278
Neurophysiological examination of dorsal sural nerve 277
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 277
NERVE EXCITABILITY TESTING IN ANIMAL MODELS OF OXALIPLATIN INDUCED PERIPHERAL NEUROTOXICITY: ION CHANNEL DYSFUNCTION AS A POSSIBLE PATHOGENETIC MECHANISM. 273
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial 272
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 272
Incidence, characteristics, and associations of oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: Results of a prospective, multicenter, international study. 270
When progressive dysphagia could be related to an “old friend” – a case report 269
Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data 268
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 267
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 266
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 264
The significance of dorsal sural nerve recordings in early detecting oxaliplatin-induced peripheral neuropathy. 262
Oxaliplatin neurotoxicity: morpho-functional approach 260
Chemotherapy-induced neuropathy 260
Totale 36.873
Salva come PNG Salva come JPEG
Categoria #
all - tutte 195.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 195.771
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.432 0 0 0 179 171 165 79 91 112 130 174 331
2022/20233.550 434 806 333 313 272 575 78 193 251 69 121 105
2023/20243.401 112 168 174 158 389 706 623 161 240 94 95 481
2024/20259.336 449 1.032 827 426 789 378 681 327 944 1.207 848 1.428
2025/202629.144 5.256 3.124 3.576 2.170 2.273 1.281 3.313 1.137 1.783 1.962 1.588 1.681
2026/20276.503 1.584 1.724 2.790 405 0 0 0 0 0 0 0 0
Totale 65.926